I think we can all agree that there are a lot of unanswered questions surrounding proton therapy, especially for prostate cancer.
Fortunately, there is an open clinical trial that needs thoughtful and opinionated doctors like you to enroll prostate cancer patients using the modality you think is best. Neither X-rays or protons are going to disappear any time soon, but at least we'll have a better understanding of what it's like for patients going through treatment with them, in terms of safety, quality of life, and 10-year cure rate.
The COMPPARE trial is still open and accruing patients to both the proton and IMRT arms. See: comppare.org There is still time to participate. To enroll a patient on the IMRT arm, you don't have to change the way you practice at all, but the patient has to be willing to complete quality of life surveys (like the IPSS and SHIM on steroids) before, during and after radiation, and agree to be followed for 10 years. They get paid around $250 for their time. You and the patient are in control of his treatment.
Protons don't have to be available at your site, just IMRT. You can treat low, intermediate or high risk patients, but not Very High Risk (patients must have at least a 10 year life expectancy). You can treat nodes if you feel it's needed. You can use SpaceOAR, or not. You can use whatever IMRT fractionation and total dose you normally would. It's a very pragmatic comparison of how patients fare with the way things are currently being done with protons and IMRT nationwide. Some sites offer both IMRT and protons and enroll in both arms, many sites offer a single modality.
If you'd like to contribute in a meaningful way, please reach out to Dr. Nancy Mendenhall, she's the nationwide PI of this federally-funded trial. Proton patients are accruing well; IMRT patients are not enrolling as quickly. There seems to be either a lack of awareness or reluctance on the part of IMRT-based physicians to generate this type of data. If your site isn't already participating, please email her, it's:
[email protected]. She's always been very helpful with my questions about the trial.